(1)
Blauvelt, A. .; Wollenberg, A.; Pink, A.; Peris, K. .; Armstrong , A.; Spelman, L.; Saeki, H.; Lynde, C.; Herranz, P.; Barbarot, S.; Simpson, E. Assessing Long-Term Maintenance of Efficacy With Tralokinumab Monotherapy in Patients With Moderate-to-Severe Atopic Dermatitis: Combined Results from Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials (ECZTRA 1 and 2). J of Skin 2021, 5, s57.